Coronavirus Update: Novartis Joins Vaccine Efforts With Gene Therapy Approach
Plus: Oxford BioMedica, And Rehab Needs Of COVID-19 Survivors
Having kept out of the race to develop a vaccine until now, Novartis has joined efforts with a collaboration using the AAV gene therapy vector.
